Intravitreal Nesvacumab plus Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Trial

被引：0
|
作者：
Boyer, David S. [1 ]
机构：
[1] Retina Vitreous Assoc Med Grp, Ophthalmol, Los Angeles, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3620
引用
收藏
页数：2
相关论文
共 50 条
  • [1] INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA Phase 2 RUBY Randomized Trial
    Brown, David M.
    Boyer, David S.
    Csaky, Karl
    Vitti, Robert
    Perlee, Lorah
    Chu, Karen W.
    Asmus, Friedrich
    Leal, Sergio
    Zeitz, Oliver
    Cheng, Yenchieh
    Schmelter, Thomas
    Heier, Jeffrey S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (06): : 1111 - 1120
  • [2] Intravitreal Aflibercept for Diabetic Macular Edema
    Korobelnik, Jean-Francois
    Do, Diana V.
    Schmidt-Erfurth, Ursula
    Boyer, David S.
    Holz, Frank G.
    Heier, Jeffrey S.
    Midena, Edoardo
    Kaiser, Peter K.
    Terasaki, Hiroko
    Marcus, Dennis M.
    Nguyen, Quan D.
    Jaffe, Glenn J.
    Slakter, Jason S.
    Simader, Christian
    Soo, Yuhwen
    Schmelter, Thomas
    Yancopoulos, George D.
    Stahl, Neil
    Vitti, Robert
    Berliner, Alyson J.
    Zeitz, Oliver
    Metzig, Carola
    Brown, David M.
    OPHTHALMOLOGY, 2014, 121 (11) : 2247 - 2254
  • [3] Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
    Klein K.A.
    Cleary T.S.
    Reichel E.
    International Journal of Retina and Vitreous, 3 (1)
  • [4] Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial
    Heier, Jeffrey S.
    Ho, Allen C.
    Boyer, David S.
    Csaky, Karl
    Vitti, Robert
    Perlee, Lorah
    Chu, Karen W.
    Asmus, Friedrich
    Leal, Sergio
    Zeitz, Oliver
    Cheng, Yenchieh
    Schmelter, Thomas
    Brown, David M.
    JOURNAL OF VITREORETINAL DISEASES, 2023, 7 (01) : 8 - 15
  • [5] Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
    Tatsumi, Tomoaki
    Takatsuna, Yoko
    Oshitari, Toshiyuki
    Kaiho, Tomomi
    Kawasaki, Yohei
    Shiko, Yuki
    Sugawara, Takeshi
    Baba, Takayuki
    Yamamoto, Shuichi
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
    Tomoaki Tatsumi
    Yoko Takatsuna
    Toshiyuki Oshitari
    Tomomi Kaiho
    Yohei Kawasaki
    Yuki Shiko
    Takeshi Sugawara
    Takayuki Baba
    Shuichi Yamamoto
    Scientific Reports, 12
  • [7] Efficacy of intravitreal aflibercept injection in eyes with diabetic macular edema
    Shimizu, Norihiro
    Oshitari, Toshiyuki
    Tatsumi, Tomoaki
    Sato, Eiju
    Takatsuna, Yoko
    Yamamoto, Shuichi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [8] Intravitreal aflibercept for diabetic macular edema: structural and functional improvements
    Zhang, Chuanhe
    Chen, Tianyu
    Jia, Ru
    Gong, Di
    Liu, Zhigao
    Wu, Changlong
    Shu, Xiangwen
    Han, Fangju
    Gong, Bin
    FRONTIERS IN MEDICINE, 2025, 12
  • [9] Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema: Evaluating the Impact on Diabetic Retinopathy
    Mitchell, Paul
    Gillies, Mark C.
    Larsen, Michael
    Staurenghi, Giovanni
    Holz, Frank G.
    Katz, Todd A.
    Lu, Chengxing
    Ahlers, Christiane
    Metzig, Carola
    Zeitz, Oliver
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [10] Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
    Tomoya Murakami
    Fumiki Okamoto
    Yoshimi Sugiura
    Shohei Morikawa
    Yoshifumi Okamoto
    Takahiro Hiraoka
    Tetsuro Oshika
    Scientific Reports, 12
12345